Clinical Trials Directory

Trials / Completed

CompletedNCT03773380

Breathe Anew for Lung Cancer Survivorship

Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (actual)
Sponsor
St. Joseph's Healthcare Hamilton · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Survivorship programs have become an integral component of modern cancer care programs. In Canada, there has been tremendous success for survivorship programs for breast, prostate, and colorectal cancer, however lung cancer survivorship programs have not been widely developed. The complexity of the disease, high mortality, short survival times, high cost of surveillance, and patient habits have traditionally been barriers against the success of lung cancer survivorship programs. The investigator proposes a feasibility study to pilot a novel intervention titled Breathe Anew, which will aim to identify and overcome the barriers to the design and implementation of a lung cancer survivorship program. The investigator has assembled a multi-disciplinary team of experts and lung cancer survivors who will develop the Breathe Anew survivorship intervention. The intervention will be vetted using an integrated knowledge translation approach, which will involve members of the target population, primarily patients who previously underwent lung resection, to modify the intervention and ensure acceptability. After Breathe Anew has been designed, it will be tested in a pilot study of 50 patients to ensure its feasibility and determine its cost. The ultimate goal of this feasibility study is to lay the groundwork for a subsequent comparative trial to evaluate the impact of Breathe Anew on patient-important outcomes including health related quality and length of life and postoperative complications.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTBreathe Anew Survivorship ProgramThe feasibility will be tested of the Breathe Anew Survivorship Program

Timeline

Start date
2019-01-02
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2018-12-12
Last updated
2022-03-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03773380. Inclusion in this directory is not an endorsement.

Breathe Anew for Lung Cancer Survivorship (NCT03773380) · Clinical Trials Directory